Status:
UNKNOWN
DWI in the Diagnosis of Histological Types of Nephroblastoma in Children
Lead Sponsor:
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Conditions:
Nephroblastoma (Wilms Tumour)
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
Initially, or after preoperative chemotherapy, patients with a kidney tumor are examined on 3T MR scanner or 1.5T MR scanner. A standard MRI study of the abdomen with contrast enhancement is performed...
Detailed Description
Initially, or after preoperative chemotherapy, patients with a kidney tumor are examined on 3T MR scanner or 1.5T MR scanner, using 8-channel body coil. A standard MRI study of the abdomen with contra...
Eligibility Criteria
Inclusion
- Age under 18 y.o.;
- Renal mass with confirmed histology.
Exclusion
- Absolute contraindications to magnetic resonance imaging (pacemaker, ferromagnetic implants, etc.);
- Refusal to sign the informed consent.
Key Trial Info
Start Date :
December 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 21 2023
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT04814758
Start Date
December 21 2020
End Date
December 21 2023
Last Update
March 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dmitry Rogachev National Medical Research Centre of Pediatric Hematology, Oncology and Immunology
Moscow, Russia